16S rRNA and Metagenomics Combined with UPLC-Q/TOF-MS Metabolomics Analysis Reveals the Potential Mechanism of Radix Astragali Against Hyperuricemia in Mice
Song Deng,Kaiwei Cai,Chaoying Pei,Xingyuan Zhang,Xiaoyi Xiao,Ye Chen,Ying Chen,Rongyao Liang,Yanlong Chen,Pei Li,Zhiyong Xie,Qiongfeng Liao
DOI: https://doi.org/10.2147/dddt.s407983
2023-05-06
Abstract:Song Deng, 1, &ast Kaiwei Cai, 1, &ast Chaoying Pei, 1 Xingyuan Zhang, 1 Xiaoyi Xiao, 1 Ye Chen, 1 Ying Chen, 1 Rongyao Liang, 1 Yanlong Chen, 1 Pei Li, 1 Zhiyong Xie, 2 Qiongfeng Liao 1 1 School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; 2 School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiongfeng Liao, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, People's Republic of China, Tel/Fax +86 02039358081, Email Zhiyong Xie, School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou, 510006, People's Republic of China, Tel/Fax +86 075523260207, Email Purpose: This study aimed to investigate the underlying treatment mechanism of Radix Astragali (RA) in hyperuricemia from the perspective of microbiota and metabolomics. Methods: We used potassium oxyazinate (PO) to induce hyperuricemia mice, and we determined serum alanine aminotransferase/aspartate aminotransferase (ALT/AST), xanthine oxidase (XOD), creatinine (CRE), uric acid (UA), blood urea nitrogen (BUN) levels, liver XOD levels and assessed the kidney tissue histopathology. The therapeutic mechanism of RA in hyperuricemic mice was studied by 16S rRNA, metagenomic sequencing and metabolomics. Results: Our research showed that RA has therapeutic effect in hyperuricemia mice, such as slow the weight loss, repair kidney damage, and downregulate serum UA, XOD, CRE, ALT/AST, BUN, and liver XOD levels. RA restored the disturbance structure of the microbiota in hyperuricemia mice by increasing the relative abundances of beneficial bacteria (Lactobacillaceae and Lactobacillus murine ) but decreasing the relative abundances of pathogenic bacteria (Prevotellaceae, Rikenellaceae and Bacteroidaceae). Meanwhile, we found that RA directly regulated the metabolic pathway (such as linoleic acid metabolism and glycerophospholipid metabolism) and indirectly regulated bile acid metabolism by mediating microbiota to ameliorate metabolic disorders. Subsequently, there was a robust correlation between specific microbiota, metabolites and the disease index. Conclusion: The ability of RA to protect mice against hyperuricemia is strongly linked to the microbiome-metabolite axis, which would provide evidence for RA as a medicine to prevent or treat hyperuricemia. Graphical Keywords: Radix Astragali, hyperuricemia, microbiota, metabolism, bile acid Graphical Hyperuricemia is a disease caused by irregular purine metabolism, which is always accompanied by excessive production or abnormal excretion of uric acid (UA). 1 Most notably, the overall incidence of hyperuricemia in China has been increasing over the past decade with the westernization of eating habits. 2,3 However, there are blind spots and misunderstandings in its diagnosis, prevention and treatment. 4 Obviously, there are several only UA-lowering medicines in the clinic, such as allopurinol (ALL) and benzbromarone. 5 Unfortunately, these chemical drugs are not suitable for a long-term and effective therapeutic schedule due to the reported side effects, 6 especially hepatorenal toxicity. Hence, it is necessary to seek a safer and more valid strategy to treat hyperuricemia. Many scholars have proposed the concept of the gut-kidney axis. Indeed, evidence suggests that kidney diseases are inextricably linked to the gut and even the gut microbiome. 7,8 Interestingly, UA, as the final product of purine metabolism in vivo, is generally produced and excreted in a dynamic balance, with 2/3 excreted by kidney and 1/3 decomposed through the intestine. 9 More importantly, much evidence has shown that the intestinal microflora is involved in purine-to-UA metabolism. 10 For example, the absorption of purine in intestinal cells can be lessened for utilization and consumption by Lactobacillus. In addition, XOD, an enzyme that can catalyze the generation of hypoxanthine to UA, induces Shiga toxigenic Escherichia coli to increase virulence. 11,12 In conclusion, disorders of the gut microbiota play an important role in the occurrence and development of hyperuricemia. Hence, maintaining the homeostasis of intestinal flora and restoring the altered microbial metabolism might be a promising strategy for treating hyperuricemia. Radix Astragali, the roots of Astragalus membranaceu -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal